Pharmacological and safety profile of dexlansoprazole: A new proton pump inhibitor - implications for treatment of gastroesophageal reflux disease in the Asia Pacific region
Khean Lee Goh*, Myung Gyu Choi, Ping I. Hsu, Hoon Jai Chun, Varocha Mahachai, Udom Kachintorn, Somchai Leelakusolvong, Nayoung Kim, Abdul Aziz Rani, Benjamin C.Y. Wong, Justin Wu, Cheng Tang Chiu, Vikram Shetty, Joseph C. Bocobo, Melchor M. Chan, Jaw Town Lin
*此作品的通信作者
- University of Malaya
- The Catholic University of Korea
- Veterans General Hospital-Kaohsiung Taiwan
- Korea University
- Chulalongkorn University
- Mahidol University
- Seoul National University
- University of Indonesia
- The University of Hong Kong
- Chinese University of Hong Kong
- Chang Gung Memorial Hospital
- Takeda Pharmaceuticals (Asia Pacific) Pte Ltd
- St. Luke's College of Medicine-William H. Quasha Memorial
- University of Santo Tomas
- Fu Jen Catholic University
研究成果: 期刊稿件 › 文獻綜述 › 同行評審
16
引文
斯高帕斯(Scopus)